Cancer Patients Pain Can Be Helped By Psychosocial Interventions

Up to one-third of cancer patients experience moderate to severe pain

 

Tampa, Fla. (Jan. 30, 2012) – Researchers at Moffitt Cancer Center, who teamed with colleagues at five universities around the United States, analyzed past studies of cancer-related pain reduction and found that psychosocial interventions can have a beneficial effect on cancer patients’ pain severity. They also found that certain psychosocial interventions provide better pain management and are effective in reducing the degree to which pain related to cancer and its treatment interferes with patients’ lives.

 

Their analysis was published in a recent online issue of the Journal of Clinical Oncology.

 

"Pain is one of the most common, burdensome and feared symptoms experienced by patients with cancer," said Paul B. Jacobsen, Ph.D., associate center director for Moffitt’s Division of Population Science. "Our study looked at randomized, controlled studies of psychosocial interventions for pain published between 1966 and 2010 in which pain was measured as an outcome in adults with cancer, or in adults undergoing procedures to diagnose cancer."

 

According to the authors, cancer-related pain can arise for a variety of reasons, including direct tumor involvement, metastasis to bone or organs, treatment toxicity and diagnostic procedures. Moderate to severe pain – suffered by up to one-third of cancer patients – often interferes with sleep, daily activities, enjoyment of life, and work and social interactions.

 

In their analysis of past pain intervention studies, the researchers investigated separately data on pain severity and data on how pain may interfere with daily life. While there is a significant body of literature devoted to study of cancer pain intervention, the authors note that not all studies they surveyed measured pain as a primary outcome. Moreover, pain was measured inconsistently across the studies.

 

When 37 past studies were analyzed to assess the effects of psychosocial interventions on patient pain, the researchers found that the most successful psychosocial, non-pharmacological pain interventions were either skill-based interventions or educational. Skill-based interventions focused on changes in the ways in which patients interpret pain, while educational approaches provided instruction on how to better use medications or helped patients more effectively communicate with clinicians about their unrelieved pain.

 

"Skill-based interventions focus on changing a patient’s dysfunctional beliefs about pain and promote the use of skills – such as distraction and relaxation – to manage it," explained Jacobsen.

 

The authors noted that their findings on the value of psychosocial interventions are consistent with the recommendations of both the Institute of Medicine (IOM) and the American Pain Society. Both organizations recommend the use of psychosocial interventions as part of a "multimodal" approach to the treatment of cancer-related pain as well as the inclusion of experts in psychosocial care as members of the multidisciplinary care team.

 

The researchers concluded that psychosocial interventions worked equally well in reducing pain across patient demographic characteristics, such as sex and racial/ethnic subgroups. However, because the majority of the available patient data was on white females, the researchers recommend further study to determine if the same interventions could better manage pain across different subgroups of patients with cancer and in different treatment settings – a strategy also suggested by the IOM.

 

"In short, we found that psychosocial interventions, including skills instruction and education can improve cancer pain management," concluded Jacobsen.

 

—-

 

About Moffitt Cancer Center

Follow Moffitt on Facebook: www.facebook.com/MoffittCancerCenter
Follow Moffitt on Twitter: @MoffittNews
Follow Moffitt on YouTube: MoffittNews

 

Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center – a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 14 affiliates in Florida, one in Georgia, one in Pennsylvania and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of "America’s Best Hospitals" for cancer.

 


 

Moffitt Cancer Center, 30.01.2012 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung